Copyright © 1997 by the European Society of Cardiology.
© 1997 The European Society of Cardiology
The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality
Robert Koch Institute Berlin, Germany
revised 13 March 1997; accepted 21 March 1997.
Correspondence: Gert B. M. Mensink, Robert Koch Institute, Berlin, General-Pape-Strasse 62-66, 12101 Berlin, Germany
Abstract
AIMS: The association between resting heart rate and changes in heart rate with all-cause, cardiovascular and cancer mortality was studied among 1827 men and 2929 women, aged 40–80 years, followed for 12 years.
METHODS AND RESULTS: After adjustment for initial age, serum cholesterol, body mass index, systolic blood pressure, smoking and diabetes, the all-cause mortality hazard ratio was 1·7 (95% confidence interval 1·4–2·2) for heart rate increments of 20 beats.min–1 for men and 1·4 (confidence interval 1·1–1·8) for women. For cardiovascular mortality, the risk estimates were 1·7 (confidence interval 1·2–2·6) for men and 1·3 (confidence interval 0·9–2·0) for women. We observed no significant association between heart rate and cancer mortality. For women, stronger predictive information for all-cause mortality was provided if changes in heart rate were evident at the 2-year review.
CONCLUSION: The resting heart rate is a predictor of mortality, independent of major cardiovascular risk factors.
Key Words: Heart rate • all-cause mortality • cardiovascular mortality • cardiovascular risk factors • change • cancer
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-C. Tardif The pivotal role of heart rate in clinical practice: from atherosclerosis to acute coronary syndrome Eur. Heart J. Suppl., August 1, 2008; 10(suppl_F): F11 - F16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A S Hall and S Palmer The heart rate hypothesis: ready to be tested Heart, May 1, 2008; 94(5): 561 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cucherat Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials Eur. Heart J., December 2, 2007; 28(24): 3012 - 3019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hjalmarson Heart rate: an independent risk factor in cardiovascular disease Eur. Heart J. Suppl., September 1, 2007; 9(suppl_F): F3 - F7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Black, L Murray, C Cardwell, G Davey Smith, and P McCarron Secular trends in heart rate in young adults, 1949 to 2004: analyses of cross sectional studies Heart, April 1, 2006; 92(4): 468 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Savonen, T. A. Lakka, J. A. Laukkanen, P. M. Halonen, T. H. Rauramaa, J. T. Salonen, and R. Rauramaa Heart rate response during exercise test and cardiovascular mortality in middle-aged men Eur. Heart J., March 1, 2006; 27(5): 582 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tendera Editorial: If inhibition: from pure heart reduction to treatment of stable angina Eur. Heart J. Suppl., September 1, 2005; 7(suppl_H): H3 - H6. [Full Text] [PDF]
|
|
|
|
 |
|
 J.-B. Ruidavets, S. Cassadou, M. Cournot, V. Bataille, M. Meybeck, and J. Ferrieres Increased resting heart rate with pollutants in a population based study J. Epidemiol. Community Health, August 1, 2005; 59(8): 685 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Diaz, M. G. Bourassa, M.-C. Guertin, and J.-C. Tardif Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease Eur. Heart J., May 2, 2005; 26(10): 967 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gullestad, J. Wikstrand, P. Deedwania, A. Hjalmarson, K. Egstrup, U. Elkayam, S. Gottlieb, A. Rashkow, H. Wedel, G. Bermann, et al. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker?: Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF) J. Am. Coll. Cardiol., January 18, 2005; 45(2): 252 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Singh Diabetes, Heart Rate, and Mortality Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 117 - 129. [Abstract] [PDF]
|
|
|
|
|
|
F Thomas, K Bean, L Guize, S Quentzel, P Argyriadis, and A Benetos Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women Eur. Heart J., April 1, 2002; 23(7): 528 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. N. Singh Morbidity and Mortality in Cardiovascular Disorders: Impact of Reduced Heart Rate Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2001; 6(4): 313 - 331. [PDF]
|
|
|
|
 |
|
 F. Seccareccia, F. Pannozzo, F. Dima, A. Minoprio, A. Menditto, C. Lo Noce, and S. Giampaoli Heart Rate as a Predictor of Mortality: The MATISS Project Am J Public Health, August 1, 2001; 91(8): 1258 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Kerber, E. O'Brien, K. R. Smith, and R. M. Cawthon Familial Excess Longevity in Utah Genealogies J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2001; 56(3): 130B - 139. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Aline Charles, A. Fontbonne, N. Thibult, J.-R. Claude, J.-M. Warnet, G. Rosselin, P. Ducimetiere, and E. Eschwege High Plasma Nonesterified Fatty Acids Are Predictive of Cancer Mortality but Not of Coronary Heart Disease Mortality: Results from the Paris Prospective Study Am. J. Epidemiol., February 1, 2001; 153(3): 292 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. GROTE, T. PLOCH, J. HEITMANN, L. KNAACK, T. PENZEL, and J. H. PETER Sleep-related Breathing Disorder Is an Independent Risk Factor for Systemic Hypertension Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1875 - 1882. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. V. Huikuri, V. Jokinen, M. Syvanne, M. S. Nieminen, K. E. J. Airaksinen, M. J. Ikaheimo, J. M. Koistinen, H. Kauma, A. Y. Kesaniemi, S. Majahalme, et al. Heart Rate Variability and Progression of Coronary Atherosclerosis Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1979 - 1985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Laperche, D Logeart, A Cohen-Solal, and R Gourgon Potential interests of heart rate lowering drugs Heart, April 1, 1999; 81(4): 336 - 341. [Full Text]
|
|
|
|
 |
|
 A. Benetos, A. Rudnichi, F. Thomas, M. Safar, and L. Guize Influence of Heart Rate on Mortality in a French Population : Role of Age, Gender, and Blood Pressure Hypertension, January 1, 1999; 33(1): 44 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Benetos, A. Rudnichi, M. Safar, and L. Guize Pulse Pressure and Cardiovascular Mortality in Normotensive and Hypertensive Subjects Hypertension, September 1, 1998; 32(3): 560 - 564. [Abstract] [Full Text] [PDF]
|
|